GLP-1 medications can come with side effects—these are the vitamins and supplements that helped me navigate and manage them ...

Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...

Eli Lilly’s new Zepbound KwikPen delivers four weekly obesity-treatment doses from a single device, aiming to make injections less of a hassle. Alongside convenience, safe handling and disposal of ...

Zepbound and Mounjaro are brand-name injections with the same active ingredient: tirzepatide. Neither Zepbound nor Mounjaro is available as a generic drug. However, various forms of compounded ...

Contrave and Zepbound are two U.S. Food and Drug Administration (FDA)-approved medications for weight loss when combined with diet and exercise. But each medication works in different ways in the body ...

Eli Lilly currently holds a patent on both drugs through 2036.

Eli Lilly Canada announced today that Health Canada has approved ZEPBOUND® (tirzepatide injection) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity (BMI 30 ...

Eli Lilly will begin offering its popular new weight-loss drug Zepbound in vials—in addition to standard injection-pen devices—at about half the price of the original for certain doses. To date, ...

Medicare coverage includes doctor visits, hospital stays, and medicines. As of July 1, 2026, Medicare now covers GLP-1's for ...

President Donald Trump struck landmark deals with Eli Lilly and Novo Nordisk to slash the prices of their blockbuster weight loss drugs. Under the agreements, the monthly out-of-pocket cost of popular ...

If you want to talk to your health care provider about weight loss medications, Saxenda and Zepbound are two options you may ...